1-10 of 10
Gianluca Masi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study

Available to Purchase
Subject Area:
Oncology
Mara Persano, Andrea Casadei-Gardini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Federico Rossari, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Francesca Bergamo, Elisabeth Amadeo, Francesco Vitiello, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Massimo Alberto Iavarone, Giuseppe Cabibbo, Margarida Montes, Francesco Giuseppe Foschi, Caterina Vivaldi, Caterina Soldà, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Mariangela Bruccoleri, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Luigi Mascia, Silvia Foti, Silvia Camera, Fabio Piscaglia, Mario Scartozzi, Stefano Cascinu, Margherita Rimini
Journal: Oncology
Oncology (2025) 103 (6): 456–468.
https://doi.org/10.1159/000541018
Published Online: 11 October 2024
View articletitled, Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study
Open the PDF for Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study in another window
Journal Articles

Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology

Free
Subject Area:
Oncology
Caterina Vivaldi, Virginia Genovesi, Clara Ugolini, Laura Bernardini, Andrea Casadei-Gardini, Vincenzo Formica, Francesca Salani, Giulia Orsi, Valentina Massa, Andrea Cacciato-Insilla, Miriam Caccese, Silvia Cesario, Kalliopi Andrikou, Jessica Graziani, Daniela Campani, Enrico Vasile, Gabriella Fontanini, Lorenzo Fornaro, Gianluca Masi
Journal: Oncology
Oncology (2024) 102 (2): 157–167.
https://doi.org/10.1159/000533406
Published Online: 12 September 2023
View articletitled, Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology
Open the PDF for Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology in another window
Journal Articles

Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy

Available to Purchase
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Oncology
Irene Pecora, Clara Ugolini, Riccardo Giannini, Mirella Giordano, Caterina Vivaldi, Monica Lencioni, Stefano Santi, Valentina Massa, Giovanni Pallabazzer, Silvia Catanese, Francesca Salani, Mario Antonio Belluomini, Enrico Vasile, Chiara Cremolini, Gabriella Fontanini, Gianluca Masi, Lorenzo Fornaro
Journal: Oncology
Oncology (2023) 101 (7): 435–445.
https://doi.org/10.1159/000530853
Published Online: 12 June 2023
View articletitled, Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy
Open the PDF for Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy in another window
Journal Articles

Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

Free
Subject Area:
Karger e-Journal Backfile Collection 2023 , Oncology
Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Bernardo Stefanini, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Valentina Burgio, Angelo Della Corte, Francesca Ratti, Francesco De Cobelli, Luca Aldrighetti, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini
Journal: Oncology
Oncology (2023) 101 (5): 283–291.
https://doi.org/10.1159/000528818
Published Online: 19 January 2023
View articletitled, Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
Open the PDF for Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab in another window
Journal Articles

Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients

Available to Purchase
Subject Area:
Oncology
Elisa Paolicchi, Caterina Vivaldi, Veronica De Gregorio, Francesco Crea, Lorenzo Fornaro, Gianluca Masi, Fotios Loupakis, Francesco Graziano, Monica Ronzoni, Vincenzo Ricci, Alfredo Falcone, Romano Danesi
Journal: Oncology
Oncology (2016) 91 (5): 283–288.
https://doi.org/10.1159/000448004
Published Online: 31 August 2016
View articletitled, Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients
Open the PDF for Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients in another window
Journal Articles

Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?

Available to Purchase
Subject Area:
Oncology
Irene Bargellini, Alessandra Scionti, Valeria Mismas, Gianluca Masi, Caterina Vivaldi, Carlo Bartolozzi, Rodolfo Sacco
Journal: Oncology
Oncology (2014) 86 (4): 191–198.
https://doi.org/10.1159/000358599
Published Online: 30 April 2014
View articletitled, Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?
Open the PDF for Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward? in another window
Journal Articles

A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

Available to Purchase
Subject Area:
Oncology
Daniele Santini, Vladimir Virzi, Enrico Vasile, Bruno Vincenzi, Vincenzo Catalano, Francesco Graziano, Gianluca Masi, Giuseppe Bronte, Antonio Russo, Alfredo Falcone, Giuseppe Tonini
Journal: Oncology
Oncology (2012) 82 (2): 75–82.
https://doi.org/10.1159/000329079
Published Online: 07 February 2012
View articletitled, A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
Open the PDF for A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients in another window
Journal Articles

5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer

Available to Purchase
Subject Area:
Oncology
Alfredo Falcone, Giacomo Allegrini, Gianluca Masi, Monica Lencioni, Elisabetta Pfanner, Isa Brunetti, Romano Danesi, Guido Bocci, Mario Del Tacca, Pierfranco Conte
Journal: Oncology
Oncology (2001) 61 (1): 28–35.
https://doi.org/10.1159/000055349
Published Online: 23 July 2001
View articletitled, 5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer
Open the PDF for 5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer in another window
Journal Articles

Oral Doxifluridine in Advanced Hepatocellular Carcinoma: A Phase II Study

Available to Purchase
Subject Area:
Oncology
Monica Lencioni, Alfredo Falcone, Giacomo Allegrini, Elisabetta Pfanner, Gianluca Masi, Isa Brunetti, Roberta Di Marsico, Eloise Fontana, Cinzia Orlandini, Corrado Gallo Stampino, Carlo Bartolozzi, Pier Franco Conte
Journal: Oncology
Oncology (2000) 59 (3): 204–209.
https://doi.org/10.1159/000012162
Published Online: 02 October 2000
View articletitled, Oral Doxifluridine in Advanced Hepatocellular Carcinoma: A Phase II Study
Open the PDF for Oral Doxifluridine in Advanced Hepatocellular Carcinoma: A Phase II Study in another window
Journal Articles

Infusions of Fluorouracil and Leucovorin: Effects of the Timing and Semi-Intermittency of Drug Delivery

Available to Purchase
Subject Area:
Oncology
Alfredo Falcone, Giacomo Allegrini, Andrea Antonuzzo, Isa Brunetti, Elisabetta Pfanner, Monica Lencioni, Gianluca Masi, Romano Danesi, Mario Del Tacca, Pierfranco Conte
Journal: Oncology
Oncology (1999) 57 (3): 195–201.
https://doi.org/10.1159/000012031
Published Online: 14 October 1999
View articletitled, Infusions of Fluorouracil and Leucovorin: Effects of the Timing and Semi-Intermittency of Drug Delivery
Open the PDF for Infusions of Fluorouracil and Leucovorin: Effects of the Timing and Semi-Intermittency of Drug Delivery in another window